SLX4 and Friedreich ataxia: Ubiquitin binding by SLX4 is required for cellular resistance specifically toward DNA cross-linking agents (Kim et al., 2013), and mutations in SLX4 confer a FA phenotype in humans, highlighting the importance of SLX4 for ICL repair (Kim et al., 2011; Stoepker et al., 2011).